EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14,464 | -79.9% | 12,258 | +41.1% | 0.00% | – |
| Q1 2022 | $72,000 | +620.0% | 8,685 | +344.9% | 0.00% | – |
| Q4 2021 | $10,000 | -72.2% | 1,952 | -55.8% | 0.00% | – |
| Q3 2020 | $36,000 | +3500.0% | 4,419 | +2109.5% | 0.00% | – |
| Q1 2020 | $1,000 | -66.7% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | – | 200 | +2757.1% | 0.00% | – |
| Q2 2019 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 7 | -65.0% | 0.00% | – |
| Q4 2016 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 20 | -99.4% | 0.00% | -100.0% |
| Q1 2016 | $57,000 | – | 3,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 595,238 | $4,845,000 | 3.97% |
| P.A.W. CAPITAL CORP | 360,000 | $2,930,000 | 3.19% |
| Telemetry Investments, L.L.C. | 124,320 | $1,012,000 | 2.20% |
| Soleus Capital Management, L.P. | 472,558 | $3,847,000 | 2.04% |
| Copernicus Capital Management, LLC | 238,151 | $1,939,000 | 1.85% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,226,000 | 1.80% |
| Trellus Management Company, LLC | 200,000 | $1,628,000 | 1.67% |
| 683 Capital Management, LLC | 2,622,914 | $21,350,000 | 1.56% |
| KNOTT DAVID M | 275,348 | $2,241,000 | 1.32% |
| MANGROVE PARTNERS IM, LLC | 1,092,394 | $8,892,000 | 1.12% |